Pharma & Healthcare
Global Infantile Spasms Therapeutics Sales Market Report, Competitive Analysis and Regional Opportunities 2025-2031
- May 05, 25
- ID: 219733
- Pages: 78
- Figures: 76
- Views: 38
The global Infantile Spasms Therapeutics market size was US$ 152 million in 2024 and is forecast to a readjusted size of US$ 194 million by 2031 with a CAGR of 3.6% during the forecast period 2025-2031.
An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.
Global Infantile Spasms Therapeutics key players include Mallinckrodt, H. Lundbeck, etc. Global top two manufacturers hold a share over 60%.
In terms of product, Oral is the largest segment, with a share obout 55%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.
The global Infantile Spasms Therapeutics market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Mallinckrodt
H. Lundbeck
Insys Therapeutics
Orphelia Pharma
Valerion Therapeutics
Catalyst Pharmaceuticals
Anavex Life Sciences
Retrophin
GW Pharmaceuticals
By Type: (Dominant Segment vs High-Margin Innovation)
Oral
Injection
By Application: (Core Demand Driver vs Emerging Opportunity)
Hospital
Clinic
Other
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Mallinckrodt in Europe)
- Emerging Product Trends: Oral adoption vs. Injection premiumization
- Demand-Side Dynamics: Hospital growth in China vs. Clinic potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
South Korea
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Infantile Spasms Therapeutics market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Injection in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Clinic in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Infantile Spasms Therapeutics value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.
Global Infantile Spasms Therapeutics key players include Mallinckrodt, H. Lundbeck, etc. Global top two manufacturers hold a share over 60%.
In terms of product, Oral is the largest segment, with a share obout 55%. And in terms of application, the largest application is Hospital, followed by Clinic, etc.
The global Infantile Spasms Therapeutics market is strategically segmented by company, region (country), by Type, and by Application. This report empowers stakeholders to capitalize on emerging opportunities, optimize product strategies, and outperform competitors through data-driven insights on revenue and forecasts across regions, by Type, and by Application for 2020-2031.
Market Segmentation
By Company:
Mallinckrodt
H. Lundbeck
Insys Therapeutics
Orphelia Pharma
Valerion Therapeutics
Catalyst Pharmaceuticals
Anavex Life Sciences
Retrophin
GW Pharmaceuticals
By Type: (Dominant Segment vs High-Margin Innovation)
Oral
Injection
By Application: (Core Demand Driver vs Emerging Opportunity)
Hospital
Clinic
Other
By Region
Macro-Regional Analysis: Market Size & Growth Forecasts
- North America
- Europe
- Asia-Pacific
- South America
- Middle East & Africa
Micro-Local Market Deep Dive: Strategic Insights
- Competitive Landscape: Player dominance vs. disruptors (e.g., Mallinckrodt in Europe)
- Emerging Product Trends: Oral adoption vs. Injection premiumization
- Demand-Side Dynamics: Hospital growth in China vs. Clinic potential in North America
- Localized Consumer Needs: Regulatory hurdles in EU vs. price sensitivity in India
Focus Markets:
North America
Europe
China
Japan
South Korea
Chapter Outline
Chapter 1: Report scope, executive summary, and market evolution scenarios (short/mid/long term).
Chapter 2: Quantitative analysis of Infantile Spasms Therapeutics market size and growth potential at global, regional, and country levels.
Chapter 3: Competitive benchmarking of manufacturers (revenue, market share, M&A, R&D focus).
Chapter 4: Type-based segmentation analysis – Uncovering blue ocean markets (e.g., Injection in China).
Chapter 5: Application-based segmentation analysis – High-growth downstream opportunities (e.g., Clinic in India).
Chapter 6: Regional revenue breakdown by company, type, application and customer.
Chapter 7: Key manufacturer profiles – Financials, product portfolios, and strategic developments.
Chapter 8: Market dynamics – Drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 9: Actionable conclusions and strategic recommendations.
Why This Report?
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Infantile Spasms Therapeutics value chain, addressing:
- Market entry risks/opportunities by region
- Product mix optimization based on local practices
- Competitor tactics in fragmented vs. consolidated markets
1 Report Overview
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infantile Spasms Therapeutics Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Infantile Spasms Therapeutics Revenue Market Share by Region (2020-2025)
2.4 Global Infantile Spasms Therapeutics Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Infantile Spasms Therapeutics Market Size and Prospective (2020-2031)
2.5.2 Europe Infantile Spasms Therapeutics Market Size and Prospective (2020-2031)
2.5.3 China Infantile Spasms Therapeutics Market Size and Prospective (2020-2031)
2.5.4 Japan Infantile Spasms Therapeutics Market Size and Prospective (2020-2031)
2.5.5 South Korea Infantile Spasms Therapeutics Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Infantile Spasms Therapeutics Historic Market Size by Type (2020-2025)
3.2 Global Infantile Spasms Therapeutics Forecasted Market Size by Type (2026-2031)
3.3 Different Types Infantile Spasms Therapeutics Representative Players
4 Breakdown Data by Application
4.1 Global Infantile Spasms Therapeutics Historic Market Size by Application (2020-2025)
4.2 Global Infantile Spasms Therapeutics Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Infantile Spasms Therapeutics Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Infantile Spasms Therapeutics Players by Revenue (2020-2025)
5.1.2 Global Infantile Spasms Therapeutics Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Infantile Spasms Therapeutics Revenue
5.4 Global Infantile Spasms Therapeutics Market Concentration Analysis
5.4.1 Global Infantile Spasms Therapeutics Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Infantile Spasms Therapeutics Revenue in 2024
5.5 Global Key Players of Infantile Spasms Therapeutics Head office and Area Served
5.6 Global Key Players of Infantile Spasms Therapeutics, Product and Application
5.7 Global Key Players of Infantile Spasms Therapeutics, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Infantile Spasms Therapeutics Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Infantile Spasms Therapeutics Market Size by Type (2020-2025)
6.1.2.2 North America Infantile Spasms Therapeutics Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Infantile Spasms Therapeutics Market Size by Application (2020-2025)
6.1.3.2 North America Infantile Spasms Therapeutics Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Infantile Spasms Therapeutics Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Infantile Spasms Therapeutics Market Size by Type (2020-2025)
6.2.2.2 Europe Infantile Spasms Therapeutics Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Infantile Spasms Therapeutics Market Size by Application (2020-2025)
6.2.3.2 Europe Infantile Spasms Therapeutics Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Infantile Spasms Therapeutics Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Infantile Spasms Therapeutics Market Size by Type (2020-2025)
6.3.2.2 China Infantile Spasms Therapeutics Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Infantile Spasms Therapeutics Market Size by Application (2020-2025)
6.3.3.2 China Infantile Spasms Therapeutics Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Infantile Spasms Therapeutics Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Infantile Spasms Therapeutics Market Size by Type (2020-2025)
6.4.2.2 Japan Infantile Spasms Therapeutics Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Infantile Spasms Therapeutics Market Size by Application (2020-2025)
6.4.3.2 Japan Infantile Spasms Therapeutics Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 South Korea Market: Players, Segments and Downstream
6.5.1 South Korea Infantile Spasms Therapeutics Revenue by Company (2020-2025)
6.5.2 South Korea Market Size by Type
6.5.2.1 South Korea Infantile Spasms Therapeutics Market Size by Type (2020-2025)
6.5.2.2 South Korea Infantile Spasms Therapeutics Market Share by Type (2020-2025)
6.5.3 South Korea Market Size by Application
6.5.3.1 South Korea Infantile Spasms Therapeutics Market Size by Application (2020-2025)
6.5.3.2 South Korea Infantile Spasms Therapeutics Market Share by Application (2020-2025)
6.5.4 South Korea Market Trend and Opportunities
7 Key Players Profiles
7.1 Mallinckrodt
7.1.1 Mallinckrodt Company Details
7.1.2 Mallinckrodt Business Overview
7.1.3 Mallinckrodt Infantile Spasms Therapeutics Introduction
7.1.4 Mallinckrodt Revenue in Infantile Spasms Therapeutics Business (2020-2025)
7.1.5 Mallinckrodt Recent Development
7.2 H. Lundbeck
7.2.1 H. Lundbeck Company Details
7.2.2 H. Lundbeck Business Overview
7.2.3 H. Lundbeck Infantile Spasms Therapeutics Introduction
7.2.4 H. Lundbeck Revenue in Infantile Spasms Therapeutics Business (2020-2025)
7.2.5 H. Lundbeck Recent Development
7.3 Insys Therapeutics
7.3.1 Insys Therapeutics Company Details
7.3.2 Insys Therapeutics Business Overview
7.3.3 Insys Therapeutics Infantile Spasms Therapeutics Introduction
7.3.4 Insys Therapeutics Revenue in Infantile Spasms Therapeutics Business (2020-2025)
7.3.5 Insys Therapeutics Recent Development
7.4 Orphelia Pharma
7.4.1 Orphelia Pharma Company Details
7.4.2 Orphelia Pharma Business Overview
7.4.3 Orphelia Pharma Infantile Spasms Therapeutics Introduction
7.4.4 Orphelia Pharma Revenue in Infantile Spasms Therapeutics Business (2020-2025)
7.4.5 Orphelia Pharma Recent Development
7.5 Valerion Therapeutics
7.5.1 Valerion Therapeutics Company Details
7.5.2 Valerion Therapeutics Business Overview
7.5.3 Valerion Therapeutics Infantile Spasms Therapeutics Introduction
7.5.4 Valerion Therapeutics Revenue in Infantile Spasms Therapeutics Business (2020-2025)
7.5.5 Valerion Therapeutics Recent Development
7.6 Catalyst Pharmaceuticals
7.6.1 Catalyst Pharmaceuticals Company Details
7.6.2 Catalyst Pharmaceuticals Business Overview
7.6.3 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Introduction
7.6.4 Catalyst Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (2020-2025)
7.6.5 Catalyst Pharmaceuticals Recent Development
7.7 Anavex Life Sciences
7.7.1 Anavex Life Sciences Company Details
7.7.2 Anavex Life Sciences Business Overview
7.7.3 Anavex Life Sciences Infantile Spasms Therapeutics Introduction
7.7.4 Anavex Life Sciences Revenue in Infantile Spasms Therapeutics Business (2020-2025)
7.7.5 Anavex Life Sciences Recent Development
7.8 Retrophin
7.8.1 Retrophin Company Details
7.8.2 Retrophin Business Overview
7.8.3 Retrophin Infantile Spasms Therapeutics Introduction
7.8.4 Retrophin Revenue in Infantile Spasms Therapeutics Business (2020-2025)
7.8.5 Retrophin Recent Development
7.9 GW Pharmaceuticals
7.9.1 GW Pharmaceuticals Company Details
7.9.2 GW Pharmaceuticals Business Overview
7.9.3 GW Pharmaceuticals Infantile Spasms Therapeutics Introduction
7.9.4 GW Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (2020-2025)
7.9.5 GW Pharmaceuticals Recent Development
8 Infantile Spasms Therapeutics Market Dynamics
8.1 Infantile Spasms Therapeutics Industry Trends
8.2 Infantile Spasms Therapeutics Market Drivers
8.3 Infantile Spasms Therapeutics Market Challenges
8.4 Infantile Spasms Therapeutics Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
1.1 Study Scope
1.2 Market by Type
1.2.1 Global Market Size Growth by Type: 2020 VS 2024 VS 2031
1.2.2 Oral
1.2.3 Injection
1.3 Market by Application
1.3.1 Global Market Share by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Infantile Spasms Therapeutics Market Perspective (2020-2031)
2.2 Global Market Size by Region: 2020 VS 2024 VS 2031
2.3 Global Infantile Spasms Therapeutics Revenue Market Share by Region (2020-2025)
2.4 Global Infantile Spasms Therapeutics Revenue Forecast by Region (2026-2031)
2.5 Major Region and Emerging Market Analysis
2.5.1 North America Infantile Spasms Therapeutics Market Size and Prospective (2020-2031)
2.5.2 Europe Infantile Spasms Therapeutics Market Size and Prospective (2020-2031)
2.5.3 China Infantile Spasms Therapeutics Market Size and Prospective (2020-2031)
2.5.4 Japan Infantile Spasms Therapeutics Market Size and Prospective (2020-2031)
2.5.5 South Korea Infantile Spasms Therapeutics Market Size and Prospective (2020-2031)
3 Breakdown Data by Type
3.1 Global Infantile Spasms Therapeutics Historic Market Size by Type (2020-2025)
3.2 Global Infantile Spasms Therapeutics Forecasted Market Size by Type (2026-2031)
3.3 Different Types Infantile Spasms Therapeutics Representative Players
4 Breakdown Data by Application
4.1 Global Infantile Spasms Therapeutics Historic Market Size by Application (2020-2025)
4.2 Global Infantile Spasms Therapeutics Forecasted Market Size by Application (2026-2031)
4.3 New Sources of Growth in Infantile Spasms Therapeutics Application
5 Competition Landscape by Players
5.1 Global Top Players by Revenue
5.1.1 Global Top Infantile Spasms Therapeutics Players by Revenue (2020-2025)
5.1.2 Global Infantile Spasms Therapeutics Revenue Market Share by Players (2020-2025)
5.2 Global Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
5.3 Players Covered: Ranking by Infantile Spasms Therapeutics Revenue
5.4 Global Infantile Spasms Therapeutics Market Concentration Analysis
5.4.1 Global Infantile Spasms Therapeutics Market Concentration Ratio (CR5 and HHI)
5.4.2 Global Top 10 and Top 5 Companies by Infantile Spasms Therapeutics Revenue in 2024
5.5 Global Key Players of Infantile Spasms Therapeutics Head office and Area Served
5.6 Global Key Players of Infantile Spasms Therapeutics, Product and Application
5.7 Global Key Players of Infantile Spasms Therapeutics, Date of Enter into This Industry
5.8 Mergers & Acquisitions, Expansion Plans
6 Region Analysis
6.1 North America Market: Players, Segments and Downstream
6.1.1 North America Infantile Spasms Therapeutics Revenue by Company (2020-2025)
6.1.2 North America Market Size by Type
6.1.2.1 North America Infantile Spasms Therapeutics Market Size by Type (2020-2025)
6.1.2.2 North America Infantile Spasms Therapeutics Market Share by Type (2020-2025)
6.1.3 North America Market Size by Application
6.1.3.1 North America Infantile Spasms Therapeutics Market Size by Application (2020-2025)
6.1.3.2 North America Infantile Spasms Therapeutics Market Share by Application (2020-2025)
6.1.4 North America Market Trend and Opportunities
6.2 Europe Market: Players, Segments and Downstream
6.2.1 Europe Infantile Spasms Therapeutics Revenue by Company (2020-2025)
6.2.2 Europe Market Size by Type
6.2.2.1 Europe Infantile Spasms Therapeutics Market Size by Type (2020-2025)
6.2.2.2 Europe Infantile Spasms Therapeutics Market Share by Type (2020-2025)
6.2.3 Europe Market Size by Application
6.2.3.1 Europe Infantile Spasms Therapeutics Market Size by Application (2020-2025)
6.2.3.2 Europe Infantile Spasms Therapeutics Market Share by Application (2020-2025)
6.2.4 Europe Market Trend and Opportunities
6.3 China Market: Players, Segments and Downstream
6.3.1 China Infantile Spasms Therapeutics Revenue by Company (2020-2025)
6.3.2 China Market Size by Type
6.3.2.1 China Infantile Spasms Therapeutics Market Size by Type (2020-2025)
6.3.2.2 China Infantile Spasms Therapeutics Market Share by Type (2020-2025)
6.3.3 China Market Size by Application
6.3.3.1 China Infantile Spasms Therapeutics Market Size by Application (2020-2025)
6.3.3.2 China Infantile Spasms Therapeutics Market Share by Application (2020-2025)
6.3.4 China Market Trend and Opportunities
6.4 Japan Market: Players, Segments and Downstream
6.4.1 Japan Infantile Spasms Therapeutics Revenue by Company (2020-2025)
6.4.2 Japan Market Size by Type
6.4.2.1 Japan Infantile Spasms Therapeutics Market Size by Type (2020-2025)
6.4.2.2 Japan Infantile Spasms Therapeutics Market Share by Type (2020-2025)
6.4.3 Japan Market Size by Application
6.4.3.1 Japan Infantile Spasms Therapeutics Market Size by Application (2020-2025)
6.4.3.2 Japan Infantile Spasms Therapeutics Market Share by Application (2020-2025)
6.4.4 Japan Market Trend and Opportunities
6.5 South Korea Market: Players, Segments and Downstream
6.5.1 South Korea Infantile Spasms Therapeutics Revenue by Company (2020-2025)
6.5.2 South Korea Market Size by Type
6.5.2.1 South Korea Infantile Spasms Therapeutics Market Size by Type (2020-2025)
6.5.2.2 South Korea Infantile Spasms Therapeutics Market Share by Type (2020-2025)
6.5.3 South Korea Market Size by Application
6.5.3.1 South Korea Infantile Spasms Therapeutics Market Size by Application (2020-2025)
6.5.3.2 South Korea Infantile Spasms Therapeutics Market Share by Application (2020-2025)
6.5.4 South Korea Market Trend and Opportunities
7 Key Players Profiles
7.1 Mallinckrodt
7.1.1 Mallinckrodt Company Details
7.1.2 Mallinckrodt Business Overview
7.1.3 Mallinckrodt Infantile Spasms Therapeutics Introduction
7.1.4 Mallinckrodt Revenue in Infantile Spasms Therapeutics Business (2020-2025)
7.1.5 Mallinckrodt Recent Development
7.2 H. Lundbeck
7.2.1 H. Lundbeck Company Details
7.2.2 H. Lundbeck Business Overview
7.2.3 H. Lundbeck Infantile Spasms Therapeutics Introduction
7.2.4 H. Lundbeck Revenue in Infantile Spasms Therapeutics Business (2020-2025)
7.2.5 H. Lundbeck Recent Development
7.3 Insys Therapeutics
7.3.1 Insys Therapeutics Company Details
7.3.2 Insys Therapeutics Business Overview
7.3.3 Insys Therapeutics Infantile Spasms Therapeutics Introduction
7.3.4 Insys Therapeutics Revenue in Infantile Spasms Therapeutics Business (2020-2025)
7.3.5 Insys Therapeutics Recent Development
7.4 Orphelia Pharma
7.4.1 Orphelia Pharma Company Details
7.4.2 Orphelia Pharma Business Overview
7.4.3 Orphelia Pharma Infantile Spasms Therapeutics Introduction
7.4.4 Orphelia Pharma Revenue in Infantile Spasms Therapeutics Business (2020-2025)
7.4.5 Orphelia Pharma Recent Development
7.5 Valerion Therapeutics
7.5.1 Valerion Therapeutics Company Details
7.5.2 Valerion Therapeutics Business Overview
7.5.3 Valerion Therapeutics Infantile Spasms Therapeutics Introduction
7.5.4 Valerion Therapeutics Revenue in Infantile Spasms Therapeutics Business (2020-2025)
7.5.5 Valerion Therapeutics Recent Development
7.6 Catalyst Pharmaceuticals
7.6.1 Catalyst Pharmaceuticals Company Details
7.6.2 Catalyst Pharmaceuticals Business Overview
7.6.3 Catalyst Pharmaceuticals Infantile Spasms Therapeutics Introduction
7.6.4 Catalyst Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (2020-2025)
7.6.5 Catalyst Pharmaceuticals Recent Development
7.7 Anavex Life Sciences
7.7.1 Anavex Life Sciences Company Details
7.7.2 Anavex Life Sciences Business Overview
7.7.3 Anavex Life Sciences Infantile Spasms Therapeutics Introduction
7.7.4 Anavex Life Sciences Revenue in Infantile Spasms Therapeutics Business (2020-2025)
7.7.5 Anavex Life Sciences Recent Development
7.8 Retrophin
7.8.1 Retrophin Company Details
7.8.2 Retrophin Business Overview
7.8.3 Retrophin Infantile Spasms Therapeutics Introduction
7.8.4 Retrophin Revenue in Infantile Spasms Therapeutics Business (2020-2025)
7.8.5 Retrophin Recent Development
7.9 GW Pharmaceuticals
7.9.1 GW Pharmaceuticals Company Details
7.9.2 GW Pharmaceuticals Business Overview
7.9.3 GW Pharmaceuticals Infantile Spasms Therapeutics Introduction
7.9.4 GW Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (2020-2025)
7.9.5 GW Pharmaceuticals Recent Development
8 Infantile Spasms Therapeutics Market Dynamics
8.1 Infantile Spasms Therapeutics Industry Trends
8.2 Infantile Spasms Therapeutics Market Drivers
8.3 Infantile Spasms Therapeutics Market Challenges
8.4 Infantile Spasms Therapeutics Market Restraints
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Global Infantile Spasms Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Infantile Spasms Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Infantile Spasms Therapeutics Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Infantile Spasms Therapeutics Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Infantile Spasms Therapeutics Revenue Share by Region (2020-2025)
Table 6. Global Infantile Spasms Therapeutics Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Infantile Spasms Therapeutics Revenue Share Forecast by Region (2026-2031)
Table 8. Global Infantile Spasms Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Infantile Spasms Therapeutics Revenue Market Share by Type (2020-2025)
Table 10. Global Infantile Spasms Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Infantile Spasms Therapeutics Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Infantile Spasms Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Infantile Spasms Therapeutics Revenue Market Share by Application (2020-2025)
Table 15. Global Infantile Spasms Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Infantile Spasms Therapeutics Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Infantile Spasms Therapeutics Application
Table 18. Global Infantile Spasms Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Infantile Spasms Therapeutics Market Share by Players (2020-2025)
Table 20. Global Top Infantile Spasms Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infantile Spasms Therapeutics as of 2024)
Table 21. Ranking of Global Top Infantile Spasms Therapeutics Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Infantile Spasms Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Infantile Spasms Therapeutics, Headquarters and Area Served
Table 24. Global Key Players of Infantile Spasms Therapeutics, Product and Application
Table 25. Global Key Players of Infantile Spasms Therapeutics, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Infantile Spasms Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Infantile Spasms Therapeutics Revenue Market Share by Company (2020-2025)
Table 29. North America Infantile Spasms Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Infantile Spasms Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Infantile Spasms Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Infantile Spasms Therapeutics Revenue Market Share by Company (2020-2025)
Table 33. Europe Infantile Spasms Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Infantile Spasms Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Infantile Spasms Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Infantile Spasms Therapeutics Revenue Market Share by Company (2020-2025)
Table 37. China Infantile Spasms Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Infantile Spasms Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Infantile Spasms Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Infantile Spasms Therapeutics Revenue Market Share by Company (2020-2025)
Table 41. Japan Infantile Spasms Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Infantile Spasms Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 43. South Korea Infantile Spasms Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 44. South Korea Infantile Spasms Therapeutics Revenue Market Share by Company (2020-2025)
Table 45. South Korea Infantile Spasms Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 46. South Korea Infantile Spasms Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 47. Mallinckrodt Company Details
Table 48. Mallinckrodt Business Overview
Table 49. Mallinckrodt Infantile Spasms Therapeutics Product
Table 50. Mallinckrodt Revenue in Infantile Spasms Therapeutics Business (2020-2025) & (US$ Million)
Table 51. Mallinckrodt Recent Development
Table 52. H. Lundbeck Company Details
Table 53. H. Lundbeck Business Overview
Table 54. H. Lundbeck Infantile Spasms Therapeutics Product
Table 55. H. Lundbeck Revenue in Infantile Spasms Therapeutics Business (2020-2025) & (US$ Million)
Table 56. H. Lundbeck Recent Development
Table 57. Insys Therapeutics Company Details
Table 58. Insys Therapeutics Business Overview
Table 59. Insys Therapeutics Infantile Spasms Therapeutics Product
Table 60. Insys Therapeutics Revenue in Infantile Spasms Therapeutics Business (2020-2025) & (US$ Million)
Table 61. Insys Therapeutics Recent Development
Table 62. Orphelia Pharma Company Details
Table 63. Orphelia Pharma Business Overview
Table 64. Orphelia Pharma Infantile Spasms Therapeutics Product
Table 65. Orphelia Pharma Revenue in Infantile Spasms Therapeutics Business (2020-2025) & (US$ Million)
Table 66. Orphelia Pharma Recent Development
Table 67. Valerion Therapeutics Company Details
Table 68. Valerion Therapeutics Business Overview
Table 69. Valerion Therapeutics Infantile Spasms Therapeutics Product
Table 70. Valerion Therapeutics Revenue in Infantile Spasms Therapeutics Business (2020-2025) & (US$ Million)
Table 71. Valerion Therapeutics Recent Development
Table 72. Catalyst Pharmaceuticals Company Details
Table 73. Catalyst Pharmaceuticals Business Overview
Table 74. Catalyst Pharmaceuticals Infantile Spasms Therapeutics Product
Table 75. Catalyst Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (2020-2025) & (US$ Million)
Table 76. Catalyst Pharmaceuticals Recent Development
Table 77. Anavex Life Sciences Company Details
Table 78. Anavex Life Sciences Business Overview
Table 79. Anavex Life Sciences Infantile Spasms Therapeutics Product
Table 80. Anavex Life Sciences Revenue in Infantile Spasms Therapeutics Business (2020-2025) & (US$ Million)
Table 81. Anavex Life Sciences Recent Development
Table 82. Retrophin Company Details
Table 83. Retrophin Business Overview
Table 84. Retrophin Infantile Spasms Therapeutics Product
Table 85. Retrophin Revenue in Infantile Spasms Therapeutics Business (2020-2025) & (US$ Million)
Table 86. Retrophin Recent Development
Table 87. GW Pharmaceuticals Company Details
Table 88. GW Pharmaceuticals Business Overview
Table 89. GW Pharmaceuticals Infantile Spasms Therapeutics Product
Table 90. GW Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (2020-2025) & (US$ Million)
Table 91. GW Pharmaceuticals Recent Development
Table 92. Infantile Spasms Therapeutics Market Trends
Table 93. Infantile Spasms Therapeutics Market Drivers
Table 94. Infantile Spasms Therapeutics Market Challenges
Table 95. Infantile Spasms Therapeutics Market Restraints
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Infantile Spasms Therapeutics Product Picture
Figure 2. Global Infantile Spasms Therapeutics Market Share by Type: 2024 VS 2031
Figure 3. Oral Features
Figure 4. Injection Features
Figure 5. Global Infantile Spasms Therapeutics Market Share by Application: 2024 VS 2031
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Other
Figure 9. Infantile Spasms Therapeutics Report Years Considered
Figure 10. Global Infantile Spasms Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 11. Global Infantile Spasms Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Infantile Spasms Therapeutics Revenue Market Share by Region: 2020 VS 2024
Figure 13. North America Infantile Spasms Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 14. Europe Infantile Spasms Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. China Infantile Spasms Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Japan Infantile Spasms Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. South Korea Infantile Spasms Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Global Infantile Spasms Therapeutics Market Share by Players in 2024
Figure 19. Global Top Infantile Spasms Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infantile Spasms Therapeutics as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Infantile Spasms Therapeutics Revenue in 2024
Figure 21. North America Infantile Spasms Therapeutics Market Share by Type (2020-2025)
Figure 22. North America Infantile Spasms Therapeutics Market Share by Application (2020-2025)
Figure 23. Europe Infantile Spasms Therapeutics Market Share by Type (2020-2025)
Figure 24. Europe Infantile Spasms Therapeutics Market Share by Application (2020-2025)
Figure 25. China Infantile Spasms Therapeutics Market Share by Type (2020-2025)
Figure 26. China Infantile Spasms Therapeutics Market Share by Application (2020-2025)
Figure 27. Japan Infantile Spasms Therapeutics Market Share by Type (2020-2025)
Figure 28. Japan Infantile Spasms Therapeutics Market Share by Application (2020-2025)
Figure 29. South Korea Infantile Spasms Therapeutics Market Share by Type (2020-2025)
Figure 30. South Korea Infantile Spasms Therapeutics Market Share by Application (2020-2025)
Figure 31. Mallinckrodt Revenue Growth Rate in Infantile Spasms Therapeutics Business (2020-2025)
Figure 32. H. Lundbeck Revenue Growth Rate in Infantile Spasms Therapeutics Business (2020-2025)
Figure 33. Insys Therapeutics Revenue Growth Rate in Infantile Spasms Therapeutics Business (2020-2025)
Figure 34. Orphelia Pharma Revenue Growth Rate in Infantile Spasms Therapeutics Business (2020-2025)
Figure 35. Valerion Therapeutics Revenue Growth Rate in Infantile Spasms Therapeutics Business (2020-2025)
Figure 36. Catalyst Pharmaceuticals Revenue Growth Rate in Infantile Spasms Therapeutics Business (2020-2025)
Figure 37. Anavex Life Sciences Revenue Growth Rate in Infantile Spasms Therapeutics Business (2020-2025)
Figure 38. Retrophin Revenue Growth Rate in Infantile Spasms Therapeutics Business (2020-2025)
Figure 39. GW Pharmaceuticals Revenue Growth Rate in Infantile Spasms Therapeutics Business (2020-2025)
Figure 40. Bottom-up and Top-down Approaches for This Report
Figure 41. Data Triangulation
Figure 42. Key Executives Interviewed
Table 1. Global Infantile Spasms Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Global Infantile Spasms Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 3. Global Market Infantile Spasms Therapeutics Market Size (US$ Million) by Region:2020 VS 2024 VS 2031
Table 4. Global Infantile Spasms Therapeutics Revenue (US$ Million) Market Share by Region (2020-2025)
Table 5. Global Infantile Spasms Therapeutics Revenue Share by Region (2020-2025)
Table 6. Global Infantile Spasms Therapeutics Revenue (US$ Million) Forecast by Region (2026-2031)
Table 7. Global Infantile Spasms Therapeutics Revenue Share Forecast by Region (2026-2031)
Table 8. Global Infantile Spasms Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 9. Global Infantile Spasms Therapeutics Revenue Market Share by Type (2020-2025)
Table 10. Global Infantile Spasms Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 11. Global Infantile Spasms Therapeutics Revenue Market Share by Type (2026-2031)
Table 12. Representative Players of Each Type
Table 13. Global Infantile Spasms Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 14. Global Infantile Spasms Therapeutics Revenue Market Share by Application (2020-2025)
Table 15. Global Infantile Spasms Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 16. Global Infantile Spasms Therapeutics Revenue Market Share by Application (2026-2031)
Table 17. New Sources of Growth in Infantile Spasms Therapeutics Application
Table 18. Global Infantile Spasms Therapeutics Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Infantile Spasms Therapeutics Market Share by Players (2020-2025)
Table 20. Global Top Infantile Spasms Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infantile Spasms Therapeutics as of 2024)
Table 21. Ranking of Global Top Infantile Spasms Therapeutics Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Infantile Spasms Therapeutics Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Infantile Spasms Therapeutics, Headquarters and Area Served
Table 24. Global Key Players of Infantile Spasms Therapeutics, Product and Application
Table 25. Global Key Players of Infantile Spasms Therapeutics, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. North America Infantile Spasms Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 28. North America Infantile Spasms Therapeutics Revenue Market Share by Company (2020-2025)
Table 29. North America Infantile Spasms Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 30. North America Infantile Spasms Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 31. Europe Infantile Spasms Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 32. Europe Infantile Spasms Therapeutics Revenue Market Share by Company (2020-2025)
Table 33. Europe Infantile Spasms Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 34. Europe Infantile Spasms Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 35. China Infantile Spasms Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 36. China Infantile Spasms Therapeutics Revenue Market Share by Company (2020-2025)
Table 37. China Infantile Spasms Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 38. China Infantile Spasms Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 39. Japan Infantile Spasms Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 40. Japan Infantile Spasms Therapeutics Revenue Market Share by Company (2020-2025)
Table 41. Japan Infantile Spasms Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 42. Japan Infantile Spasms Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 43. South Korea Infantile Spasms Therapeutics Revenue by Company (2020-2025) & (US$ Million)
Table 44. South Korea Infantile Spasms Therapeutics Revenue Market Share by Company (2020-2025)
Table 45. South Korea Infantile Spasms Therapeutics Market Size by Type (2020-2025) & (US$ Million)
Table 46. South Korea Infantile Spasms Therapeutics Market Size by Application (2020-2025) & (US$ Million)
Table 47. Mallinckrodt Company Details
Table 48. Mallinckrodt Business Overview
Table 49. Mallinckrodt Infantile Spasms Therapeutics Product
Table 50. Mallinckrodt Revenue in Infantile Spasms Therapeutics Business (2020-2025) & (US$ Million)
Table 51. Mallinckrodt Recent Development
Table 52. H. Lundbeck Company Details
Table 53. H. Lundbeck Business Overview
Table 54. H. Lundbeck Infantile Spasms Therapeutics Product
Table 55. H. Lundbeck Revenue in Infantile Spasms Therapeutics Business (2020-2025) & (US$ Million)
Table 56. H. Lundbeck Recent Development
Table 57. Insys Therapeutics Company Details
Table 58. Insys Therapeutics Business Overview
Table 59. Insys Therapeutics Infantile Spasms Therapeutics Product
Table 60. Insys Therapeutics Revenue in Infantile Spasms Therapeutics Business (2020-2025) & (US$ Million)
Table 61. Insys Therapeutics Recent Development
Table 62. Orphelia Pharma Company Details
Table 63. Orphelia Pharma Business Overview
Table 64. Orphelia Pharma Infantile Spasms Therapeutics Product
Table 65. Orphelia Pharma Revenue in Infantile Spasms Therapeutics Business (2020-2025) & (US$ Million)
Table 66. Orphelia Pharma Recent Development
Table 67. Valerion Therapeutics Company Details
Table 68. Valerion Therapeutics Business Overview
Table 69. Valerion Therapeutics Infantile Spasms Therapeutics Product
Table 70. Valerion Therapeutics Revenue in Infantile Spasms Therapeutics Business (2020-2025) & (US$ Million)
Table 71. Valerion Therapeutics Recent Development
Table 72. Catalyst Pharmaceuticals Company Details
Table 73. Catalyst Pharmaceuticals Business Overview
Table 74. Catalyst Pharmaceuticals Infantile Spasms Therapeutics Product
Table 75. Catalyst Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (2020-2025) & (US$ Million)
Table 76. Catalyst Pharmaceuticals Recent Development
Table 77. Anavex Life Sciences Company Details
Table 78. Anavex Life Sciences Business Overview
Table 79. Anavex Life Sciences Infantile Spasms Therapeutics Product
Table 80. Anavex Life Sciences Revenue in Infantile Spasms Therapeutics Business (2020-2025) & (US$ Million)
Table 81. Anavex Life Sciences Recent Development
Table 82. Retrophin Company Details
Table 83. Retrophin Business Overview
Table 84. Retrophin Infantile Spasms Therapeutics Product
Table 85. Retrophin Revenue in Infantile Spasms Therapeutics Business (2020-2025) & (US$ Million)
Table 86. Retrophin Recent Development
Table 87. GW Pharmaceuticals Company Details
Table 88. GW Pharmaceuticals Business Overview
Table 89. GW Pharmaceuticals Infantile Spasms Therapeutics Product
Table 90. GW Pharmaceuticals Revenue in Infantile Spasms Therapeutics Business (2020-2025) & (US$ Million)
Table 91. GW Pharmaceuticals Recent Development
Table 92. Infantile Spasms Therapeutics Market Trends
Table 93. Infantile Spasms Therapeutics Market Drivers
Table 94. Infantile Spasms Therapeutics Market Challenges
Table 95. Infantile Spasms Therapeutics Market Restraints
Table 96. Research Programs/Design for This Report
Table 97. Key Data Information from Secondary Sources
Table 98. Key Data Information from Primary Sources
List of Figures
Figure 1. Infantile Spasms Therapeutics Product Picture
Figure 2. Global Infantile Spasms Therapeutics Market Share by Type: 2024 VS 2031
Figure 3. Oral Features
Figure 4. Injection Features
Figure 5. Global Infantile Spasms Therapeutics Market Share by Application: 2024 VS 2031
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Other
Figure 9. Infantile Spasms Therapeutics Report Years Considered
Figure 10. Global Infantile Spasms Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 11. Global Infantile Spasms Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Infantile Spasms Therapeutics Revenue Market Share by Region: 2020 VS 2024
Figure 13. North America Infantile Spasms Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 14. Europe Infantile Spasms Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 15. China Infantile Spasms Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 16. Japan Infantile Spasms Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 17. South Korea Infantile Spasms Therapeutics Revenue (US$ Million) Growth Rate (2020-2031)
Figure 18. Global Infantile Spasms Therapeutics Market Share by Players in 2024
Figure 19. Global Top Infantile Spasms Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Infantile Spasms Therapeutics as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by Infantile Spasms Therapeutics Revenue in 2024
Figure 21. North America Infantile Spasms Therapeutics Market Share by Type (2020-2025)
Figure 22. North America Infantile Spasms Therapeutics Market Share by Application (2020-2025)
Figure 23. Europe Infantile Spasms Therapeutics Market Share by Type (2020-2025)
Figure 24. Europe Infantile Spasms Therapeutics Market Share by Application (2020-2025)
Figure 25. China Infantile Spasms Therapeutics Market Share by Type (2020-2025)
Figure 26. China Infantile Spasms Therapeutics Market Share by Application (2020-2025)
Figure 27. Japan Infantile Spasms Therapeutics Market Share by Type (2020-2025)
Figure 28. Japan Infantile Spasms Therapeutics Market Share by Application (2020-2025)
Figure 29. South Korea Infantile Spasms Therapeutics Market Share by Type (2020-2025)
Figure 30. South Korea Infantile Spasms Therapeutics Market Share by Application (2020-2025)
Figure 31. Mallinckrodt Revenue Growth Rate in Infantile Spasms Therapeutics Business (2020-2025)
Figure 32. H. Lundbeck Revenue Growth Rate in Infantile Spasms Therapeutics Business (2020-2025)
Figure 33. Insys Therapeutics Revenue Growth Rate in Infantile Spasms Therapeutics Business (2020-2025)
Figure 34. Orphelia Pharma Revenue Growth Rate in Infantile Spasms Therapeutics Business (2020-2025)
Figure 35. Valerion Therapeutics Revenue Growth Rate in Infantile Spasms Therapeutics Business (2020-2025)
Figure 36. Catalyst Pharmaceuticals Revenue Growth Rate in Infantile Spasms Therapeutics Business (2020-2025)
Figure 37. Anavex Life Sciences Revenue Growth Rate in Infantile Spasms Therapeutics Business (2020-2025)
Figure 38. Retrophin Revenue Growth Rate in Infantile Spasms Therapeutics Business (2020-2025)
Figure 39. GW Pharmaceuticals Revenue Growth Rate in Infantile Spasms Therapeutics Business (2020-2025)
Figure 40. Bottom-up and Top-down Approaches for This Report
Figure 41. Data Triangulation
Figure 42. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Natural Cocoa Extracts Market Research Report 2026
May 01, 26
Global Semiconductor Switched Mode Power Supply Market Research Report 2026
May 01, 26
Global Silicone Coated Spandrel Glass Market Research Report 2026
May 01, 26
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232